Abstract:Relaxin-3 is an insulin/relaxin superfamily neuropeptide implicated in the regulation of food intake and stress response via activation of the G protein-coupled receptor RXFP3. Their electrostatic interactions have been recently identified, and involves three positively charged B-chain residues (B12Arg, B16Arg, and B26Arg) of relaxin-3 and two negatively charged residues (Glu141 and Asp145) in a highly conserved ExxxD motif at the extracellular end of the second transmembrane domain of RXFP3. To investigate their hydrophobic interactions, in the present work we deleted the highly conserved B-chain C-terminal B27Trp residue of relaxin-3, and mutated four highly conserved aromatic residues (Phe137, Trp138, Phe146, and Trp148) around the ExxxD motif of RXFP3. The resultant [∆B27W]relaxin-3 exhibited approximately tenfold lower binding potency and ~1000-fold lower activation potency towards wild-type RXFP3, confirming its importance for relaxin-3 function. Although the RXFP3 mutants could be normally trafficked to cell membrane, they had quite different activities. [F137A]RXFP3 could normally distinguish wild-type relaxin-3 and [∆B27W]relaxin-3 in binding and activation assays, whereas [W138A]RXFP3 lost most of this capability, suggesting that the Trp138 residue of RXFP3 forms hydrophobic interactions with the B27Trp residue of relaxin-3. The hydrophobic Trp138 residue and the formerly identified negatively charged Glu141 and Asp145 residues in the highly conserved WxxExxxD motif may thus form a functional surface that is important for interaction with relaxin-3. We hypothesize that the relaxin-3 B-chain C-terminus changes from the original folding-back conformation to an extended conformation during binding with RXFP3, to allow its B27Trp and B26Arg residues to interact with the Trp138 and Glu141 residues of RXFP3, respectively.

Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4

Interaction Mechanism of Insulin-Like Peptide 5 with Relaxin Family Peptide Receptor 4

Identification of Important Residues of Insulin-Like Peptide 5 and Its Receptor RXFP4 for Ligand–receptor Interactions

Exploring Receptor Selectivity of the Chimeric Relaxin Family Peptide R3/I5 by Incorporating Unnatural Amino Acids.

Development of a Selective Agonist for Relaxin Family Peptide Receptor 3

The Electrostatic Interactions of Relaxin‐3 with Receptor RXFP4 and the Influence of Its B‐chain C‐terminal Conformation

Functionality of an absolutely conserved glycine residue in the chimeric relaxin family peptide R3/I5

The Highly Conserved Negatively Charged Glu141 and Asp145 of the G-Protein-Coupled Receptor Rxfp3 Interact with the Highly Conserved Positively Charged Arginine Residues of Relaxin-3

Identification of Hydrophobic Interactions Between Relaxin-3 and Its Receptor Rxfp3: Implication for A Conformational Change in the B-Chain C-Terminus During Receptor Binding

Hydrophobic Interactions of Relaxin Family Peptide Receptor 3 with Ligands Identified Using a NanoBiT-based Binding Assay

Distinct but overlapping binding sites of agonist and antagonist at the relaxin family peptide 3 (RXFP3) receptor

Exploring the Use of Helicogenic Amino Acids for Optimising Single Chain Relaxin-3 Peptide Agonists

Relaxin family peptides: structure–activity relationship studies

A Negatively Charged Transmembrane Aspartate Residue Controls Activation of the Relaxin-3 Receptor RXFP3.

Mechanisms of biased agonism by Gα i/o -biased stapled peptide agonists of the relaxin-3 receptor

High-throughput screening campaign identifies a small molecule agonist of the relaxin family peptide receptor 4

Elucidation of relaxin-3 binding interactions in the extracellular loops of RXFP3

A Simple Approach for the Preparation of Mature Human Relaxin-3.

Exploring Electrostatic Interactions of Relaxin Family Peptide Receptor 3 and 4 with Ligands Using a NanoBiT-based Binding Assay

Design, Recombinant Expression and Convenient A‐chain N‐terminal Europium‐labelling of a Fully Active Human Relaxin‐3 Analogue

Development of a Novel Ligand Binding Assay for Relaxin Family Peptide Receptor 3 and 4 Using NanoLuc Complementation